https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:13:472024-03-15 15:12:36Developing AAV gene therapy for mitochondrial myopathies
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:12:322024-03-15 15:12:36HyperCKemia as a potential biochemical feature of Hypokalemic Periodic Paralysis
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:11:202024-03-15 15:12:36THE 5-YEAR EU PROJECT SCREEN4CARE ON GENETIC NEWBORN SCREENING – SELECTION OF TREATABLE DISEASES
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:09:522024-03-15 15:12:36A multicentre, prospective study comparing autoantibody diagnostic assays in myasthenia gravis
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:06:172024-03-15 15:12:36Preclinical assessment of the effects of the growth hormone secretagogue JMV2894 in the D2-mdx mouse model of Duchenne muscular dystrophy
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:04:272024-03-15 15:12:35Countermeasures for sarcopenia: effects of BCAA-based formulations on muscle function, histomorphology, and calcium homeostasis in aged mice.
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:03:252024-03-15 15:12:35Natural history of distal and myofibrillar myopathies assessed by clinical and technological outcome measures (Dista-Myo): longitudinal results
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:01:572024-03-15 15:12:35Need for tube feeding in SMA type I patients treated with disease modifying therapies: prognostic factors
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 11:00:442024-03-15 15:12:35Proof of concept for drug repurposing of fenamates in myotonia congenita
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 10:59:112024-03-15 15:12:35Functional characterization of the Nav1.4 sodium channel mutation, p. L689F, found in a young boy suffering from myotonia permanens.
